삼성 계열 3사, 라이프사이언스 투자조합 출자…1980억 규모

Samsung is establishing a KRW 198 billion venture investment fund focused on life sciences and emerging technologies through three subsidiary companies. This strategic move demonstrates Samsung's commitment to portfolio diversification into biotech and biopharmaceutical sectors while securing cutting-edge technologies over a 10-year period. The multi-subsidiary participation reflects Samsung's broader strategy to strengthen its ecosystem presence in the rapidly growing life sciences industry.